|
Fusion Gene Summary | |
Fusion Gene ORF analysis | |
Fusion Genomic Features | |
Fusion Protein Features | |
Fusion Gene Sequence | |
Fusion Gene PPI analysis | |
Related Drugs | |
Related Diseases |
Fusion gene:SRP72-STAT5B (FusionGDB2 ID:85869) |
Fusion Gene Summary for SRP72-STAT5B |
Fusion gene summary |
Fusion gene information | Fusion gene name: SRP72-STAT5B | Fusion gene ID: 85869 | Hgene | Tgene | Gene symbol | SRP72 | STAT5B | Gene ID | 6731 | 6777 |
Gene name | signal recognition particle 72 | signal transducer and activator of transcription 5B | |
Synonyms | BMFF|BMFS1|HEL103 | STAT5 | |
Cytomap | 4q12 | 17q21.2 | |
Type of gene | protein-coding | protein-coding | |
Description | signal recognition particle subunit SRP72epididymis luminal protein 103signal recognition particle 72 kDa proteinsignal recognition particle 72kDsignal recognition particle 72kDa | signal transducer and activator of transcription 5Btranscription factor STAT5B | |
Modification date | 20200313 | 20200313 | |
UniProtAcc | . | . | |
Ensembl transtripts involved in fusion gene | ENST00000342756, ENST00000510663, ENST00000504757, | ENST00000293328, | |
Fusion gene scores | * DoF score | 3 X 3 X 3=27 | 10 X 6 X 7=420 |
# samples | 3 | 10 | |
** MAII score | log2(3/27*10)=0.15200309344505 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(10/420*10)=-2.0703893278914 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: SRP72 [Title/Abstract] AND STAT5B [Title/Abstract] AND fusion [Title/Abstract] | ||
Most frequent breakpoint | SRP72(57357734)-STAT5B(40369482), # samples:1 | ||
Anticipated loss of major functional domain due to fusion event. |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | SRP72 | GO:0042493 | response to drug | 18089836 |
Tgene | STAT5B | GO:0032355 | response to estradiol | 12552091 |
Tgene | STAT5B | GO:0032870 | cellular response to hormone stimulus | 12552091 |
Tgene | STAT5B | GO:0045648 | positive regulation of erythrocyte differentiation | 20702587 |
Tgene | STAT5B | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway | 12552091 |
Fusion gene breakpoints across SRP72 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene breakpoints across STAT5B (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
ChimerDB4 | Non-Cancer | TCGA-L5-A43C-11A | SRP72 | chr4 | 57357734 | + | STAT5B | chr17 | 40369482 | - |
Top |
Fusion Gene ORF analysis for SRP72-STAT5B |
Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
In-frame | ENST00000342756 | ENST00000293328 | SRP72 | chr4 | 57357734 | + | STAT5B | chr17 | 40369482 | - |
In-frame | ENST00000510663 | ENST00000293328 | SRP72 | chr4 | 57357734 | + | STAT5B | chr17 | 40369482 | - |
intron-3CDS | ENST00000504757 | ENST00000293328 | SRP72 | chr4 | 57357734 | + | STAT5B | chr17 | 40369482 | - |
ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
ENST00000342756 | SRP72 | chr4 | 57357734 | + | ENST00000293328 | STAT5B | chr17 | 40369482 | - | 6126 | 2361 | 376 | 3555 | 1059 |
ENST00000510663 | SRP72 | chr4 | 57357734 | + | ENST00000293328 | STAT5B | chr17 | 40369482 | - | 5241 | 1476 | 19 | 2670 | 883 |
DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
ENST00000342756 | ENST00000293328 | SRP72 | chr4 | 57357734 | + | STAT5B | chr17 | 40369482 | - | 0.00050374 | 0.9994962 |
ENST00000510663 | ENST00000293328 | SRP72 | chr4 | 57357734 | + | STAT5B | chr17 | 40369482 | - | 0.000359781 | 0.9996402 |
Top |
Fusion Genomic Features for SRP72-STAT5B |
FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for SRP72-STAT5B |
Go to FGviewer for the breakpoints of chr4:57357734-chr17:40369482 - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. |
Main function of each fusion partner protein. (from UniProt) |
Hgene | Tgene |
. | . |
FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. | FUNCTION: Might normally function as a transcriptional repressor. EWS-fusion-proteins (EFPS) may play a role in the tumorigenic process. They may disturb gene expression by mimicking, or interfering with the normal function of CTD-POLII within the transcription initiation complex. They may also contribute to an aberrant activation of the fusion protein target genes. |
Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000342756 | + | 16 | 19 | 109_142 | 546.6666666666666 | 672.0 | Repeat | Note=TPR 2 |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000342756 | + | 16 | 19 | 11_44 | 546.6666666666666 | 672.0 | Repeat | Note=TPR 1 |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000342756 | + | 16 | 19 | 226_259 | 546.6666666666666 | 672.0 | Repeat | Note=TPR 3 |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000342756 | + | 16 | 19 | 406_439 | 546.6666666666666 | 672.0 | Repeat | Note=TPR 4 |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000342756 | + | 16 | 19 | 447_480 | 546.6666666666666 | 672.0 | Repeat | Note=TPR 5 |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000510663 | + | 14 | 17 | 109_142 | 485.6666666666667 | 611.0 | Repeat | Note=TPR 2 |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000510663 | + | 14 | 17 | 11_44 | 485.6666666666667 | 611.0 | Repeat | Note=TPR 1 |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000510663 | + | 14 | 17 | 226_259 | 485.6666666666667 | 611.0 | Repeat | Note=TPR 3 |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000510663 | + | 14 | 17 | 406_439 | 485.6666666666667 | 611.0 | Repeat | Note=TPR 4 |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000510663 | + | 14 | 17 | 447_480 | 485.6666666666667 | 611.0 | Repeat | Note=TPR 5 |
Tgene | STAT5B | chr4:57357734 | chr17:40369482 | ENST00000293328 | 8 | 19 | 589_686 | 389.6666666666667 | 788.0 | Domain | SH2 |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000342756 | + | 16 | 19 | 552_561 | 546.6666666666666 | 672.0 | Compositional bias | Note=Poly-Lys |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000342756 | + | 16 | 19 | 662_665 | 546.6666666666666 | 672.0 | Compositional bias | Note=Poly-Lys |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000510663 | + | 14 | 17 | 552_561 | 485.6666666666667 | 611.0 | Compositional bias | Note=Poly-Lys |
Hgene | SRP72 | chr4:57357734 | chr17:40369482 | ENST00000510663 | + | 14 | 17 | 662_665 | 485.6666666666667 | 611.0 | Compositional bias | Note=Poly-Lys |
Top |
Fusion Gene Sequence for SRP72-STAT5B |
For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
>In-frame_ENST00000342756_ENST00000293328_TCGA-L5-A43C-11A_SRP72_chr4_57357734_+_STAT5B_chr17_40369482_length(transcript)=6126nt_BP=2361nt GCTAAGTAACTTGTTTATTGTCAGACATCTAGTGAGTCGCAGAGCCAGGGAACTGACCACGGGCATTTTCACCCCATTACCCTTCCAGCT TATTGCCGACTGCTCCCGAAGGGAGCGAAAAGGACAGGCAAAGGGTTTCACCAAACCCTTTGTAATGGGAGATTCTTGCCTTCTTACCTT TCCTCACGTTTGCTTCTCTGCCAGAATGTCTTCCCGCACTTTCCCCAGAACCCAAGTTCTCCTAATCATCTTTCAAGATCCCTTTCCCTC AACCACAGATGAGCCGTGCCTATTTCTCCTTCAAATGACTCCCTATGGCTTCTAGTTGGTAGTCTTTTATTTACCACCTCATAGTCCTTT TATTTATATCCCATAAATGATCGTCCGGCCCCGCACCGTGGGACCAGGACGCTGCCTCGACCATGGCGGTCTCCTGGAAACAGGCTGCTT TGAGCCGAAACTGGTGACCGTTTCCCAACCCCGTCCAGGAGTCCGACGCCTCTTTTCTCCAGGCCAACTTCAAGTGAGGTGTATCAACTC TATCCGCACAAATTTCTTGCCACGAGAGCAGAAGATTATGATCTCTGATGCTGCCTTAGGGCTGAAGACACTCCCAACTCGGCGACGCTT AGCAATCATCGACTTCCTCCTCCTCTTGGCTGCCTCGGAGATCCTGTTCCGGGGCAGAGGTCTCCCCGCCCCGCCCCTCGTCTCCTCCAA GATGGCGAGCGGCGGCAGCGGGGGGGTGTCAGTACCTGCGCTGTGGAGTGAAGTGAACCGGTATGGCCAGAACGGCGACTTCACGCGCGC TCTCAAGACCGTCAATAAGATACTACAGATCAACAAAGATGACGTAACTGCCCTGCATTGTAAAGTGGTATGCCTTATCCAGAATGGAAG TTTCAAGGAAGCTTTGAATGTCATCAATACTCACACCAAAGTGTTAGCCAATAACTCTCTCTCCTTTGAAAAGGCATATTGCGAGTACAG GCTGAACAGAATTGAGAATGCCTTGAAGACAATAGAAAGTGCCAACCAGCAGACAGACAAACTGAAGGAGCTTTATGGACAAGTGTTATA CCGTTTGGAACGCTATGATGAATGCTTAGCAGTGTATAGAGATCTCGTCCGAAACTCCCAAGATGATTATGATGAGGAGAGGAAAACAAA CCTTTCAGCAGTTGTTGCAGCTCAAAGCAATTGGGAAAAAGTGGTTCCAGAGAACCTGGGCCTCCAAGAAGGCACACATGAGCTGTGCTA CAACACTGCATGTGCACTGATAGGCCAAGGCCAGCTGAACCAGGCCATGAAAATCCTACAAAAAGCTGAAGATCTTTGCCGCCGTTCATT ATCAGAAGACACTGATGGGACTGAGGAAGACCCACAGGCAGAACTGGCCATCATTCATGGTCAGATGGCTTATATTCTGCAGCTTCAGGG TCGAACAGAGGAGGCTTTGCAACTTTACAATCAAATAATAAAACTAAAACCAACAGATGTGGGATTACTAGCTGTAATTGCAAATAACAT CATTACCATTAACAAGGACCAAAATGTCTTTGACTCCAAGAAGAAAGTGAAATTAACCAATGCGGAAGGAGTAGAGTTTAAGCTTTCCAA GAAACAACTACAAGCTATAGAATTTAACAAAGCTTTACTTGCTATGTACACAAACCAGGCTGAACAATGCCGCAAAATATCTGCCAGTTT ACAGTCCCAAAGTCCCGAGCATCTCTTACCTGTGTTAATCCAAGCTGCCCAGCTCTGCCGTGAAAAGCAGCACACAAAAGCAATAGAGCT GCTTCAGGAATTTTCAGATCAGCATCCAGAAAATGCAGCTGAAATTAAGCTGACCATGGCACAGTTGAAAATTTCTCAAGGTAATATTTC TAAAGCATGTCTAATATTGAGAAGCATAGAGGAGTTAAAGCATAAACCAGGCATGGTATCTGCATTAGTTACCATGTATAGCCATGAAGA AGATATTGATAGTGCCATTGAGGTCTTCACACAAGCTATCCAGTGGTATCAAAACCATCAGCCAAAATCTCCTGCTCATTTGTCCTTGAT AAGAGAAGCTGCAAACTTCAAACTCAAATATGGGCGGAAGAAGGAGGCAATTAGTGACCTACAACAGCTGTGGAAACAAAATCCAAAAGA TATTCACACCCTGGCACAGCTTATTTCTGCTTACTCACTTGTAGATCCAGAGAAAGCCAAAGCTCTTAGTAAACACTTGCCATCGTCAGA TAGTATGTCTCTAAAAGTAGATGTTGAGGCTCTTGAAAATTCTGCTGGTGCTACATACATTCGGAAGAAGGGTGGAAAAGTTACTGGAGA TAGTCAACCAAAGGAACAAGGTGATTACAGTGGCGAGATCTTGAACAACTGCTGCGTCATGGAGTACCACCAAGCCACAGGCACCCTTAG TGCCCACTTCAGGAATATGTCCCTGAAACGAATTAAGAGGTCAGACCGTCGTGGGGCAGAGTCGGTGACAGAAGAAAAATTTACAATCCT GTTTGAATCCCAGTTCAGTGTTGGTGGAAATGAGCTGGTTTTTCAAGTCAAGACCCTGTCCCTGCCAGTGGTGGTGATCGTTCATGGCAG CCAGGACAACAATGCGACGGCCACTGTTCTCTGGGACAATGCTTTTGCAGAGCCTGGCAGGGTGCCATTTGCCGTGCCTGACAAAGTGCT GTGGCCACAGCTGTGTGAGGCGCTCAACATGAAATTCAAGGCCGAAGTGCAGAGCAACCGGGGCCTGACCAAGGAGAACCTCGTGTTCCT GGCGCAGAAACTGTTCAACAACAGCAGCAGCCACCTGGAGGACTACAGTGGCCTGTCTGTGTCCTGGTCCCAGTTCAACAGGGAGAATTT ACCAGGACGGAATTACACTTTCTGGCAATGGTTTGACGGTGTGATGGAAGTGTTAAAAAAACATCTCAAGCCTCATTGGAATGATGGGGC CATTTTGGGGTTTGTAAACAAGCAACAGGCCCATGACCTACTCATTAACAAGCCAGATGGGACCTTCCTCCTGAGATTCAGTGACTCAGA AATTGGCGGCATCACCATTGCTTGGAAGTTTGATTCTCAGGAAAGAATGTTTTGGAATCTGATGCCTTTTACCACCAGAGACTTCTCCAT TCGGTCCCTAGCCGACCGCTTGGGAGACTTGAATTACCTTATCTACGTGTTTCCTGATCGGCCAAAAGATGAAGTATACTCCAAATACTA CACACCAGTTCCCTGCGAGTCTGCTACTGCTAAAGCTGTTGATGGATACGTGAAGCCACAGATCAAGCAAGTGGTCCCTGAGTTTGTGAA CGCATCTGCAGATGCCGGGGGCGGCAGCGCCACGTACATGGACCAGGCCCCCTCCCCAGCTGTGTGTCCCCAGGCTCACTATAACATGTA CCCACAGAACCCTGACTCAGTCCTTGACACCGATGGGGACTTCGATCTGGAGGACACAATGGACGTAGCGCGGCGTGTGGAGGAGCTCCT GGGCCGGCCAATGGACAGTCAGTGGATCCCGCACGCACAATCGTGACCCCGCGACCTCTCCATCTTCAGCTTCTTCATCTTCACCAGAGG AATCACTCTTGTGGATGTTTTAATTCCATGAATCGCTTCTCTTTTGAAACAATACTCATAATGTGAAGTGTTAATACTAGTTGTGACCTT AGTGTTTCTGTGCATGGTGGCACCAGCGAAGGGAGTGCGAGTATGTGTTTGTGTGTGTGTGTGTGTGTGTGTGTGTGTGCGTGTTTGCAC GTTATGGTGTTTCTCCCTCTCACTGTCTGAGAGTTTAGTTGTAGCAGAGGGGCCACAGACAGAAGCTGTGGTGGTTTTTACTTTGTGCAA AAAGGCAGTGAGTTTCGTGAAGCCTGGAAGTTGGCCATGTGTCTTAAGAGTGGCTGGACTTTGACATGTGGCTGTTTGAATAAGAGAAGG ACAAAGGGAGGAGAAAGCACATGTGCTCCAGTGAGTCTTCGTCACTCTGTCTGCCAAGCAATTGATATATAACCGTGATTGTCTCTGCTT TTCTTCTGAAATGTAGATAACTGCTTTTTGACAAAGAGAGCCTTCCCTCTCCCCCACCCCTGTGTTCTTGGGTAGGAATGGGAAAAGGGG CAACCTACAAAGATTGTTGGGGCAAGGGAAGTCACAAGCTTTCGGATGGGCGGTGGCTTTTCACAAAACATTTAGCTCATCTTATTCTCT CTTTGTCCTCTCTCCCCTCCTGCCCGCCCGCACCCTGGAATTGCCACTCAGTTCCTCTGGGTGTGCACATATGTTTGGAGAAATAGAGGA GAGAAAAGAGGGCCACGTAACTGAGAGCTTACAGTGCCAATGCCGTTTGTGTTCTGGCCAGAGTGGAGTGCGCAGCCCTGACTCCCAGGC GCTGAGATTGTTGCCTGGTTACCCAGGAAGCTGCTGTTCCGGCTGCCCAGCCTTTCTCTGAGCCAGCGGATGCACAGTCCGTGGCCTTCT TCAGGCTTATTGATGATGCTTTTTGCAAATGTTGAATCATGGTTCTGTTTCTAAGTTGGATCTTTTTTGTTTTCTCCTTGCCACCCTAAT TTGACATCAAAATTCTCTCTTGTGCATTGGGCCCTGGGTCATTCAAACCCAGGTCACCTCATTCCCCTTCTCTGTTCACACCTAATGTCT TGAAGAGTAGGTAGCAGCAGTGTGGGCTGAACCTAGGCCAGCTTGCTTAGCGGGTCACCCTGCTGTGAAGTCCTGGCAGGTGTTGGTAAT GTGTGGAAATGCAGTCAGCAAGTTTGCTGGGGAGTTTGATAAAAGTATAAAACAAAACAAAAAAAGCCTCGGTATAATTTTGTTCCACGA CTTCTTCTGTAGCTTTACACCAGAAGGAAGGAATGGGCTACAGCAGGTAGTGGAGGAAGAGGGGGGTGAGCAGGTGTATTAAAATAGCTT ACGGGTAAGGCCTAAAAGGTCACCCCTCGGCCCCCTCTCCAAAAGAAGGGCATGGGCACCCCCAGGAGAGGATGGCCCCAAAAACCTTAT TTTTATACATGAGAGTAAATAAACATATTTTTTTTACAAAAATAACTTCTGAATTTATCAGTGTTTTGCCGTTAAAAATATTCCTCTATA GTAAATTATTTATTGGAAGATGACTTTTTTAAAGCTGCCGTTTGCCTTGGCTTGGTTTCATACACTGATTTATTTTTCTATGCCAGGCAG TAGAGTCTCTCTGCCTCTGAGGAGCAGGCTACCCGCATCCCACTCAGCCCCTCCCTACCCCTCAAGATTTGATGAAAATTCCAACCATGA GGATGGGTGCATCGGGGAAGGGTGAGAAGGAGAGCCTGCCTGCTCAGGGATCCAGGCTCGTAGAGTCACTCCCTGCCCGTCTCCCAGAGA TGCTTCACCAGCACCTGCCTCTGAGACCTCGCTCTCTGTTCCAGCAACCCTGGTTGGGGGGTCAGACTTGATACACTTTCAGGTTGGGAG TGGACCCACCCCAGGGCCTGCTGAGGACAGAGCAGCCAGGCCGTCCTGGCTCACTTTGCAGTTGGCACTGGGTTGGGGAGGAAGAGAGCT GATGAGTGTGGCTTCCCTGAGCTGGGGTTTCCCTGCTTGTCCAGTTGTGAGCTGTCCTCGGTGTTACCGAGGCTGTGCCTAGAGAGTGGA GATTTTTGATGAAAGGTGTGCTCGCTCTCTGCGTTCTATCTTCTCTCTCCTCCTTGTTCCTGCAAACCACAAGATAAAGGTAGTGGTGTG TCTCGACCCCATCAGCCTCTCACCCACTCCCAGACACACACAAGTCCTCAAAAGTTTCAGCTCCGTGTGTGAGATGTGCAGGTTTTTTCT AGGGGGTAGGGGGAGACTAAAATCGAATATAACTTAAAATGAAAGTATACTTTTTATAATTTTTCTTTTTAAAACTTGGTGAAATTATTT CAGATACATATTTTAGTGTCAAGGCAGATTAGTTATTTAGCCACCAAAAAAAAGTATTGTGTACAATTTGGGGCCTCAAATTTGACTCTG CCTCAAAAAAAAGAAATATATCCTATGCAGAGTTACAGTCACAAAGTTGTGTATTTTATGTTACAATAAAGCCTTCCTCTGAAGGGATGG >In-frame_ENST00000342756_ENST00000293328_TCGA-L5-A43C-11A_SRP72_chr4_57357734_+_STAT5B_chr17_40369482_length(amino acids)=1059AA_start in transcript=376_stop in transcript=3555 MIVRPRTVGPGRCLDHGGLLETGCFEPKLVTVSQPRPGVRRLFSPGQLQVRCINSIRTNFLPREQKIMISDAALGLKTLPTRRRLAIIDF LLLLAASEILFRGRGLPAPPLVSSKMASGGSGGVSVPALWSEVNRYGQNGDFTRALKTVNKILQINKDDVTALHCKVVCLIQNGSFKEAL NVINTHTKVLANNSLSFEKAYCEYRLNRIENALKTIESANQQTDKLKELYGQVLYRLERYDECLAVYRDLVRNSQDDYDEERKTNLSAVV AAQSNWEKVVPENLGLQEGTHELCYNTACALIGQGQLNQAMKILQKAEDLCRRSLSEDTDGTEEDPQAELAIIHGQMAYILQLQGRTEEA LQLYNQIIKLKPTDVGLLAVIANNIITINKDQNVFDSKKKVKLTNAEGVEFKLSKKQLQAIEFNKALLAMYTNQAEQCRKISASLQSQSP EHLLPVLIQAAQLCREKQHTKAIELLQEFSDQHPENAAEIKLTMAQLKISQGNISKACLILRSIEELKHKPGMVSALVTMYSHEEDIDSA IEVFTQAIQWYQNHQPKSPAHLSLIREAANFKLKYGRKKEAISDLQQLWKQNPKDIHTLAQLISAYSLVDPEKAKALSKHLPSSDSMSLK VDVEALENSAGATYIRKKGGKVTGDSQPKEQGDYSGEILNNCCVMEYHQATGTLSAHFRNMSLKRIKRSDRRGAESVTEEKFTILFESQF SVGGNELVFQVKTLSLPVVVIVHGSQDNNATATVLWDNAFAEPGRVPFAVPDKVLWPQLCEALNMKFKAEVQSNRGLTKENLVFLAQKLF NNSSSHLEDYSGLSVSWSQFNRENLPGRNYTFWQWFDGVMEVLKKHLKPHWNDGAILGFVNKQQAHDLLINKPDGTFLLRFSDSEIGGIT IAWKFDSQERMFWNLMPFTTRDFSIRSLADRLGDLNYLIYVFPDRPKDEVYSKYYTPVPCESATAKAVDGYVKPQIKQVVPEFVNASADA -------------------------------------------------------------- >In-frame_ENST00000510663_ENST00000293328_TCGA-L5-A43C-11A_SRP72_chr4_57357734_+_STAT5B_chr17_40369482_length(transcript)=5241nt_BP=1476nt GCCCCTCGTCTCCTCCAAGATGGCGAGCGGCGGCAGCGGGGGGGTGTCAGTACCTGCGCTGTGGAGTGAAGTGAACCGGTATGGCCAGAA CGGCGACTTCACGCGCGCTCTCAAGACCGTCAATAAGATACTACAGATCAACAAAGATGACGTAACTGCCCTGCATTGTAAAGTGGTATG CCTTATCCAGAATGGAAGTTTCAAGGAAGCTTTGAATGTCATCAATACTCACACCAAAGTGTTAGCCAATAACTCTCTCTCCTTTGAAAA GGCATATTGCGAGTACAGGCTGAACAGAATTGAGAATGCCTTGAAGACAATAGAAAGTGCCAACCAGCAGACAGACAAACTGAAGGAGCT TTATGGACAAGTGTTATACCGTTTGGAACGCTATGATGAATGCTTAGCAGTGTATAGAGATCTCGTCCGAAACTCCCAAGATGATTATGA TGAGGAGAGGAAAACAAACCTTTCAGCAGTTGTTGCAGCTCAAAGCAATTGGGAAAAAGTGGTTCCAGAGAACCTGGGCCTCCAAGAAGG CACACATGAGCTGTGCTACAACACTGCATGTGCACTGATAGGCCAAGGCCAGCTGAACCAGGCCATGAAAATCCTACAAAAAGCTGAAGA TCTTTGCCGCCGTTCATTATCAGAAGACACTGACCAAAATGTCTTTGACTCCAAGAAGAAAGTGAAATTAACCAATGCGGAAGGAGTAGA GTTTAAGCTTTCCAAGAAACAACTACAAGCTATAGAATTTAACAAAGCTTTACTTGCTATGTACACAAACCAGGCTGAACAATGCCGCAA AATATCTGCCAGTTTACAGTCCCAAAGTCCCGAGCATCTCTTACCTGTGTTAATCCAAGCTGCCCAGCTCTGCCGTGAAAAGCAGCACAC AAAAGCAATAGAGCTGCTTCAGGAATTTTCAGATCAGCATCCAGAAAATGCAGCTGAAATTAAGCTGACCATGGCACAGTTGAAAATTTC TCAAGGTAATATTTCTAAAGCATGTCTAATATTGAGAAGCATAGAGGAGTTAAAGCATAAACCAGGCATGGTATCTGCATTAGTTACCAT GTATAGCCATGAAGAAGATATTGATAGTGCCATTGAGGTCTTCACACAAGCTATCCAGTGGTATCAAAACCATCAGCCAAAATCTCCTGC TCATTTGTCCTTGATAAGAGAAGCTGCAAACTTCAAACTCAAATATGGGCGGAAGAAGGAGGCAATTAGTGACCTACAACAGCTGTGGAA ACAAAATCCAAAAGATATTCACACCCTGGCACAGCTTATTTCTGCTTACTCACTTGTAGATCCAGAGAAAGCCAAAGCTCTTAGTAAACA CTTGCCATCGTCAGATAGTATGTCTCTAAAAGTAGATGTTGAGGCTCTTGAAAATTCTGCTGGTGCTACATACATTCGGAAGAAGGGTGG AAAAGTTACTGGAGATAGTCAACCAAAGGAACAAGGTGATTACAGTGGCGAGATCTTGAACAACTGCTGCGTCATGGAGTACCACCAAGC CACAGGCACCCTTAGTGCCCACTTCAGGAATATGTCCCTGAAACGAATTAAGAGGTCAGACCGTCGTGGGGCAGAGTCGGTGACAGAAGA AAAATTTACAATCCTGTTTGAATCCCAGTTCAGTGTTGGTGGAAATGAGCTGGTTTTTCAAGTCAAGACCCTGTCCCTGCCAGTGGTGGT GATCGTTCATGGCAGCCAGGACAACAATGCGACGGCCACTGTTCTCTGGGACAATGCTTTTGCAGAGCCTGGCAGGGTGCCATTTGCCGT GCCTGACAAAGTGCTGTGGCCACAGCTGTGTGAGGCGCTCAACATGAAATTCAAGGCCGAAGTGCAGAGCAACCGGGGCCTGACCAAGGA GAACCTCGTGTTCCTGGCGCAGAAACTGTTCAACAACAGCAGCAGCCACCTGGAGGACTACAGTGGCCTGTCTGTGTCCTGGTCCCAGTT CAACAGGGAGAATTTACCAGGACGGAATTACACTTTCTGGCAATGGTTTGACGGTGTGATGGAAGTGTTAAAAAAACATCTCAAGCCTCA TTGGAATGATGGGGCCATTTTGGGGTTTGTAAACAAGCAACAGGCCCATGACCTACTCATTAACAAGCCAGATGGGACCTTCCTCCTGAG ATTCAGTGACTCAGAAATTGGCGGCATCACCATTGCTTGGAAGTTTGATTCTCAGGAAAGAATGTTTTGGAATCTGATGCCTTTTACCAC CAGAGACTTCTCCATTCGGTCCCTAGCCGACCGCTTGGGAGACTTGAATTACCTTATCTACGTGTTTCCTGATCGGCCAAAAGATGAAGT ATACTCCAAATACTACACACCAGTTCCCTGCGAGTCTGCTACTGCTAAAGCTGTTGATGGATACGTGAAGCCACAGATCAAGCAAGTGGT CCCTGAGTTTGTGAACGCATCTGCAGATGCCGGGGGCGGCAGCGCCACGTACATGGACCAGGCCCCCTCCCCAGCTGTGTGTCCCCAGGC TCACTATAACATGTACCCACAGAACCCTGACTCAGTCCTTGACACCGATGGGGACTTCGATCTGGAGGACACAATGGACGTAGCGCGGCG TGTGGAGGAGCTCCTGGGCCGGCCAATGGACAGTCAGTGGATCCCGCACGCACAATCGTGACCCCGCGACCTCTCCATCTTCAGCTTCTT CATCTTCACCAGAGGAATCACTCTTGTGGATGTTTTAATTCCATGAATCGCTTCTCTTTTGAAACAATACTCATAATGTGAAGTGTTAAT ACTAGTTGTGACCTTAGTGTTTCTGTGCATGGTGGCACCAGCGAAGGGAGTGCGAGTATGTGTTTGTGTGTGTGTGTGTGTGTGTGTGTG TGTGCGTGTTTGCACGTTATGGTGTTTCTCCCTCTCACTGTCTGAGAGTTTAGTTGTAGCAGAGGGGCCACAGACAGAAGCTGTGGTGGT TTTTACTTTGTGCAAAAAGGCAGTGAGTTTCGTGAAGCCTGGAAGTTGGCCATGTGTCTTAAGAGTGGCTGGACTTTGACATGTGGCTGT TTGAATAAGAGAAGGACAAAGGGAGGAGAAAGCACATGTGCTCCAGTGAGTCTTCGTCACTCTGTCTGCCAAGCAATTGATATATAACCG TGATTGTCTCTGCTTTTCTTCTGAAATGTAGATAACTGCTTTTTGACAAAGAGAGCCTTCCCTCTCCCCCACCCCTGTGTTCTTGGGTAG GAATGGGAAAAGGGGCAACCTACAAAGATTGTTGGGGCAAGGGAAGTCACAAGCTTTCGGATGGGCGGTGGCTTTTCACAAAACATTTAG CTCATCTTATTCTCTCTTTGTCCTCTCTCCCCTCCTGCCCGCCCGCACCCTGGAATTGCCACTCAGTTCCTCTGGGTGTGCACATATGTT TGGAGAAATAGAGGAGAGAAAAGAGGGCCACGTAACTGAGAGCTTACAGTGCCAATGCCGTTTGTGTTCTGGCCAGAGTGGAGTGCGCAG CCCTGACTCCCAGGCGCTGAGATTGTTGCCTGGTTACCCAGGAAGCTGCTGTTCCGGCTGCCCAGCCTTTCTCTGAGCCAGCGGATGCAC AGTCCGTGGCCTTCTTCAGGCTTATTGATGATGCTTTTTGCAAATGTTGAATCATGGTTCTGTTTCTAAGTTGGATCTTTTTTGTTTTCT CCTTGCCACCCTAATTTGACATCAAAATTCTCTCTTGTGCATTGGGCCCTGGGTCATTCAAACCCAGGTCACCTCATTCCCCTTCTCTGT TCACACCTAATGTCTTGAAGAGTAGGTAGCAGCAGTGTGGGCTGAACCTAGGCCAGCTTGCTTAGCGGGTCACCCTGCTGTGAAGTCCTG GCAGGTGTTGGTAATGTGTGGAAATGCAGTCAGCAAGTTTGCTGGGGAGTTTGATAAAAGTATAAAACAAAACAAAAAAAGCCTCGGTAT AATTTTGTTCCACGACTTCTTCTGTAGCTTTACACCAGAAGGAAGGAATGGGCTACAGCAGGTAGTGGAGGAAGAGGGGGGTGAGCAGGT GTATTAAAATAGCTTACGGGTAAGGCCTAAAAGGTCACCCCTCGGCCCCCTCTCCAAAAGAAGGGCATGGGCACCCCCAGGAGAGGATGG CCCCAAAAACCTTATTTTTATACATGAGAGTAAATAAACATATTTTTTTTACAAAAATAACTTCTGAATTTATCAGTGTTTTGCCGTTAA AAATATTCCTCTATAGTAAATTATTTATTGGAAGATGACTTTTTTAAAGCTGCCGTTTGCCTTGGCTTGGTTTCATACACTGATTTATTT TTCTATGCCAGGCAGTAGAGTCTCTCTGCCTCTGAGGAGCAGGCTACCCGCATCCCACTCAGCCCCTCCCTACCCCTCAAGATTTGATGA AAATTCCAACCATGAGGATGGGTGCATCGGGGAAGGGTGAGAAGGAGAGCCTGCCTGCTCAGGGATCCAGGCTCGTAGAGTCACTCCCTG CCCGTCTCCCAGAGATGCTTCACCAGCACCTGCCTCTGAGACCTCGCTCTCTGTTCCAGCAACCCTGGTTGGGGGGTCAGACTTGATACA CTTTCAGGTTGGGAGTGGACCCACCCCAGGGCCTGCTGAGGACAGAGCAGCCAGGCCGTCCTGGCTCACTTTGCAGTTGGCACTGGGTTG GGGAGGAAGAGAGCTGATGAGTGTGGCTTCCCTGAGCTGGGGTTTCCCTGCTTGTCCAGTTGTGAGCTGTCCTCGGTGTTACCGAGGCTG TGCCTAGAGAGTGGAGATTTTTGATGAAAGGTGTGCTCGCTCTCTGCGTTCTATCTTCTCTCTCCTCCTTGTTCCTGCAAACCACAAGAT AAAGGTAGTGGTGTGTCTCGACCCCATCAGCCTCTCACCCACTCCCAGACACACACAAGTCCTCAAAAGTTTCAGCTCCGTGTGTGAGAT GTGCAGGTTTTTTCTAGGGGGTAGGGGGAGACTAAAATCGAATATAACTTAAAATGAAAGTATACTTTTTATAATTTTTCTTTTTAAAAC TTGGTGAAATTATTTCAGATACATATTTTAGTGTCAAGGCAGATTAGTTATTTAGCCACCAAAAAAAAGTATTGTGTACAATTTGGGGCC TCAAATTTGACTCTGCCTCAAAAAAAAGAAATATATCCTATGCAGAGTTACAGTCACAAAGTTGTGTATTTTATGTTACAATAAAGCCTT >In-frame_ENST00000510663_ENST00000293328_TCGA-L5-A43C-11A_SRP72_chr4_57357734_+_STAT5B_chr17_40369482_length(amino acids)=883AA_start in transcript=19_stop in transcript=2670 MASGGSGGVSVPALWSEVNRYGQNGDFTRALKTVNKILQINKDDVTALHCKVVCLIQNGSFKEALNVINTHTKVLANNSLSFEKAYCEYR LNRIENALKTIESANQQTDKLKELYGQVLYRLERYDECLAVYRDLVRNSQDDYDEERKTNLSAVVAAQSNWEKVVPENLGLQEGTHELCY NTACALIGQGQLNQAMKILQKAEDLCRRSLSEDTDQNVFDSKKKVKLTNAEGVEFKLSKKQLQAIEFNKALLAMYTNQAEQCRKISASLQ SQSPEHLLPVLIQAAQLCREKQHTKAIELLQEFSDQHPENAAEIKLTMAQLKISQGNISKACLILRSIEELKHKPGMVSALVTMYSHEED IDSAIEVFTQAIQWYQNHQPKSPAHLSLIREAANFKLKYGRKKEAISDLQQLWKQNPKDIHTLAQLISAYSLVDPEKAKALSKHLPSSDS MSLKVDVEALENSAGATYIRKKGGKVTGDSQPKEQGDYSGEILNNCCVMEYHQATGTLSAHFRNMSLKRIKRSDRRGAESVTEEKFTILF ESQFSVGGNELVFQVKTLSLPVVVIVHGSQDNNATATVLWDNAFAEPGRVPFAVPDKVLWPQLCEALNMKFKAEVQSNRGLTKENLVFLA QKLFNNSSSHLEDYSGLSVSWSQFNRENLPGRNYTFWQWFDGVMEVLKKHLKPHWNDGAILGFVNKQQAHDLLINKPDGTFLLRFSDSEI GGITIAWKFDSQERMFWNLMPFTTRDFSIRSLADRLGDLNYLIYVFPDRPKDEVYSKYYTPVPCESATAKAVDGYVKPQIKQVVPEFVNA -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for SRP72-STAT5B |
Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
- Retained PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
- Lost PPIs in in-frame fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
- Retained PPIs, but lost function due to frame-shift fusion. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for SRP72-STAT5B |
Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for SRP72-STAT5B |
Diseases associated with fusion partners. (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | SRP72 | C3808553 | Bone marrow failure syndrome 1 | 2 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Hgene | SRP72 | C0008370 | Cholestasis | 1 | CTD_human |
Hgene | SRP72 | C0019193 | Hepatitis, Toxic | 1 | CTD_human |
Hgene | SRP72 | C0860207 | Drug-Induced Liver Disease | 1 | CTD_human |
Hgene | SRP72 | C1262760 | Hepatitis, Drug-Induced | 1 | CTD_human |
Hgene | SRP72 | C3658290 | Drug-Induced Acute Liver Injury | 1 | CTD_human |
Hgene | SRP72 | C4277682 | Chemical and Drug Induced Liver Injury | 1 | CTD_human |
Hgene | SRP72 | C4279912 | Chemically-Induced Liver Toxicity | 1 | CTD_human |
Tgene | STAT5B | C1855548 | Laron syndrome type 2 | 5 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
Tgene | STAT5B | C1522378 | Leukemia, Large Granular Lymphocytic | 2 | CTD_human |
Tgene | STAT5B | C1955860 | Leukemia, Natural Killer Cell Large Granular Lymphocytic | 2 | CTD_human |
Tgene | STAT5B | C1955861 | T-Cell Large Granular Lymphocyte Leukemia | 2 | CGI;CTD_human |
Tgene | STAT5B | C0023487 | Acute Promyelocytic Leukemia | 1 | CGI;ORPHANET |
Tgene | STAT5B | C0023494 | Leukemia, T-Cell, Chronic | 1 | CTD_human |
Tgene | STAT5B | C0038002 | Splenomegaly | 1 | CTD_human |
Tgene | STAT5B | C0079772 | T-Cell Lymphoma | 1 | CTD_human |
Tgene | STAT5B | C0079773 | Lymphoma, T-Cell, Cutaneous | 1 | CTD_human |
Tgene | STAT5B | C0376407 | Granulomatous Slack Skin | 1 | CTD_human |
Tgene | STAT5B | C0392788 | Nasal Type Extranodal NK/T-Cell Lymphoma | 1 | CTD_human |
Tgene | STAT5B | C0456889 | Enteropathy-Associated T-Cell Lymphoma | 1 | CTD_human |
Tgene | STAT5B | C0494261 | Combined immunodeficiency | 1 | GENOMICS_ENGLAND |
Tgene | STAT5B | C1955906 | Lymphoma, Extranodal NK-T-Cell | 1 | CTD_human |
Tgene | STAT5B | C1961099 | Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | CTD_human |
Tgene | STAT5B | C2363142 | T-Cell Prolymphocytic Leukemia | 1 | CTD_human |
Tgene | STAT5B | C2931322 | T-Lymphocytopenia | 1 | CTD_human |